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Regulation ofimmune responses by T cells is mediated by the release of soluble
factors in several systems (1-3) . These factors have the same function, antigenic
specificity, and genetic restrictions as the cells from which they are derived and
may represent a soluble or shed form of the T cell receptor for antigen . One of
the best-characterized T cell factors is generated following challenge of genetic
nonresponder mice with the antigen L-glutamic acidso-L-alanine3°-L-tyrosine'°
(GAT)' ; this factor is derived from suppressor T cells and is termed GAT-TsF
(4). Until recently, detailed information about the chemistry and mechanism of
action of this and related molecules has been hindered by the inability to obtain
sufficient amounts of material in a pure form . The development of hybridoma
techniques has allowed construction of T cell hybrids constitutively producing
sufficient quantities of factor for analysis . Recently, efficient methods for puri-
fying GAT-TsF to chemical homogeneity using immunoabsorbents and high
performance liquid chromatography (HPLC) techniques have been reported (5).
We have used modifications of these techniques for the purification of a GAT-
specific suppressor T cell factor, termed GAT-TsFR, from genetic responder
mice toGAT (6) . GAT-specific suppressor T cells (GAT-TSR cells) were induced
in responder mice by injection of neonates with GAT-pulsed syngeneic macro-
phages (GAT-MO), restimulated with GAT in vitro and hybridomas were con-
structed by fusion to the AKR thymoma, BW5147 . The GAT-TsFR purified
from hybridoma culture supernatant fluids is compared with GAT-TsF derived
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from hybridomas of nonresponder suppressor T cells and the concept of a family
of suppressor T cell molecules is discussed.
Materials and Methods
Mice.
￿
C57BL/10 mice were bred in the Animal Resources Facility of the Jewish
Hospital of St. Louis, maintained on water and laboratory chow ad libitum and used at
10-20 wk of age. Mice were vaccinated at 5 wk of age with the IHD-T strain of vaccinia
virus.
Antigens and Immunizations.
￿
GAT (45,000 mol wt, Vega Biochemicals, Tucson, AZ)
was prepared for use as antigen in culture (7), preparation of GAT-Md (8, 9) and coupling
to sheep erythrocytes (SRBC) for use as indicator cells in the hemolytic plaque assay (7),
as described. Neonatal mice were injected with 2 X 106 syngeneic GAT-Mo for the
induction of GAT-TSR, as previously described (6). Spleens were removed from these
animals at 10-20 wk of age and used for the generation of T cell hybridomas.
Generation of T Cell Hybridomas.
￿
Spleen cells from C57BL/10 mice (5 X 106/well)
injected as neonates with syngeneic GAT-Mo were restimulated with GAT in vitro and
fused with the AKR thymoma BW5147, as previously described (10-13). Individual clones
were screened for GAT-specific suppressive activity and the biological activity of super-
natant fluids from the hybridoma to be discussed, 372B3 .5, has been described in detail
(6). Supernatant fluids from BW5147 and other wells from the same fusion were consist-
ently negative for both GAT-specific and nonspecific suppressive activity.
Culture System and Hemolytic Plaque Assay.
￿
Single cell suspensions of spleen in completely
supplemented Eagle's minimal essential medium with 10% fetal calf serum (lot 52101,
Reheis Chemical Co., Kankakee, IL) were incubated at 5 X 106 cells in 0 .5 ml in 16-mm
wells of a 24-well tissue culture plate (76-033-05 ; Linbro Div., Flow Laboratories, Inc.,
Hamden, CT) for 5 d at 37°C in an atmosphere of 10% C02, 7% 02, 83% N2 under
modified Mishell-Dutton conditions (7, 8). Soluble GAT (2 tag/culture) or 107 SRBC and
appropriately diluted samples of GAT-TsFR were added to the spleen cells at culture
initiation. GAT-specific IgG and SRBC-specific IgM and IgG antibody responses were
assayed using the slide modification of the Jerne hemolytic plaque assay (7, 14). Data are
expressed as plaque-forming cells (PFC)/culture or as the inverse of the final dilution of
factor yielding 50% suppression of the PFC response (S5o U).
High Performance Liquid Chromatography (HPLC).
￿
Hybridoma supernatant fluids con-
taining GAT-TsFR were adjusted to 30% 1-propanol (vol/vol); the resulting precipitate
was removed by centrifugation (10,000 g). The propanol extract was adjusted to pH 5.5
with 2 M acetic acid and applied to a preparative column (2 .25 cm X 22.5 cm) containing
Lichroprep RP-8 (25-40 micron) (E. Merck, Darmstadt, Federal Republic of Germany).
Proteins were eluted with a stepwise reverse phase gradient of 0-60% 1-propanol in 0.5
M acetic acid/1 .0 M pyridine, pH 5.5 buffer at a flow rate of 50 ml/min. Fractions were
assessed for suppression of GAT-specific PFC responses; biologically active fractions were
pooled and adjusted to 20% 1-propanol. This material was applied to a Lichrosorb RP-8
(10 m) analytical column (0.45 cm X 22.5 cm) (Merck & Co., Rahway, NJ) and eluted
with a stepwise gradient of 1-propanol in 0.5 M acetic acid/1 .0 M pyridine, pH 5 .5 buffer
at a flow rate of 0.22 ml/min. Biologically active fractions were identified, pooled,
adjusted to 20% 1-propanol, and rechromatographed on a Lichrosorb RP-8 (10 Am)
column under the same buffer conditions and flow rates, but using an expanded propanol
gradient to increase resolution . Column effluents were monitored for protein using
fluorescamine (Hoffmann-LaRoche, Nutley, NJ) and an automated detection system (15) .
Molecular weight was determined by applying GAT-TsFR to a tandem column containing
BIO-SIL TSK 125 and TSK 250 resins (Bio-Rad Laboratories, Richmond, CA). Proteins
were eluted with 0.5 M acetic acid/ 1 .0 M pyridine, pH 5 .5 buffer using a flow rate of
0.25 ml/min. In one series of experiments, hybridoma supernatant fluids were concen-
trated by lyophilization, applied to Sephacryl S-200 columns (1 .4 cm X 50.0 cm), and
eluted with phosphate-buffered saline (0.15 M, pH 7.5) or sodium acetate (0.5 M, pH
5.0) . Fractions of 2 ml were collected and tested for biological activity.1036
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Gel Electrophoresis .
￿
Purified samples were analyzed by sodium dodecyl sulfate polyac-
rylainide gel electrophoresis (SDS-PAGE) under reducing or nonreducing conditions in
12.5% polyacrylamide gels (16) . Isoelectric focusing gels were performed as described by
Briles and Davie (17) using a pH gradient of 4 to 10 . Gels were fixed in methanol/acetic
acid/water, 50:10:40 (vol/vol/vol) and stained with silver by the method of Morrisey
(18) .
Anriiio Acid Composition Analyses.
￿
Purified GAT-TsFk from hybridoma 372B3 .5 was
Subjected to SDS-PAGE (12.5% gel) that was stained with Coomassie Brilliant Blue ;
individual bands were cut from the gel, eluted and dried in vacuo . The samples were
hydrolyzed in 6 M HCl/0 .1 % thioglycollic acid at 11 O°C for 24 h . After drying, the
samples were dissolved in 0.2 M sodium citrate/0.1% thiodiglycol, pH 2 .2 and analyzed
in a fluorescamine amino acid analyzer (19) .
Immmroadsorbents .
￿
GAT-, t.-glutainic acid"'-L-tyrosine""-(GT-) and L-glutamic acid'°-L-
alanine""-(GA-) Sepharose were provided by Dr . J . Kapp (Jewish Hospital of St . Louis,
Washington University Medical School) . Peanut agglutinin (PNA) agarose was purchased
from E-Y Laboratories, San Mateo, CA . Immunoadsorbents of monoclonal anti-1-J', anti-
IJ", and an antiidiotype (guinea pig anti-mouse anti-GAT antibody), anti-cGAT, were
prepared as described previously (6) . Purified GAT-TsFk was applied to these immuno-
adsorbents ; the effluent and material eluted with 2.0 M KCI were tested for biological
activity .
Results
Pierifrcation ofGAT-TsF, ? .
￿
Supernatant fluids from 40 1 of372B3.5 cells grown
to a density of 1 .4 X 106 cells/ml were divided into 10-liter portions and adjusted
to 30% 1-propanol (vol/vol) . The precipitate was separated by centrifugation,
the propanol-extract was applied to a preparative Lichroprep RP-8 column and
eluted with a stepwise gradient of 1-propanol in 0.5 M acetic acid/1 .0M pyridine,
pH 5 .5 buffer . Samples were removed from individual fractions and tested for
their ability to suppress an in vitro GAT-specific PFC response by spleen cells
from C57BL/10 mice . The data in Fig . 1 A show that GAT-specific suppressive
activity eluted in 40% propanol with one of several protein peaks . Similar results
were obtained for all four of the 10-liter preparations (data not shown) .
Biologically active fractions were pooled, adjusted to 20% 1-propanol, and
chromatographed on an analytical Lichrosorb RP-8 column in acetic acid/
pyridine buffer at a flow rate of 0.22 ml/min and a 0-60% 1-propanol gradient .
Biological activity eluted 25-35 min into the 40% 1-propanol step (Fig . 1 B) ;
these fractions were pooled and rechromatographed on the Lichrosorb RP-8
column under the same buffer conditions using a more shallow 0-60% 1-
propanol gradient . Biologically active protein again eluted at a position 25-40
min into the 40% 1-propanol step and was spread over several fractions, but was
within the single protein peak (Fig . 1 C) . A summary of the purification scheme,
yield, and specific activity of GAT-TsF R at each step of purification of 40 1 of
hybridoma supernatant fluid is in Table 1 . 40 1 of supernatant fluid containing
6.8 X 10- '' S50 U/ng protein was purified in three steps to yield a final specific
activity of 28.4 X 10' 550 U/ng protein representing a 4.2 X l 0'-fold purification
over the starting material . Crude supernatant fluid and HPLC-purified, biolog-
ically active protein (peak from Fig . 1 C) from hybridoma 372B3 .5 were tested
for antigen-binding capacity and presence of serologic determinants by applying
samples to various Immunoabsorbents, collecting effluents and material eluted
by 2 M KCI, and testing for biological activity . The data in Table 11 show thatW
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Purification of GAT-TsFR by reverse phase HPLC. (A) Supernatant fluids from
a 10-liter culture of hybridoma 372B3.5 were precleared by precipitation with 30% (vol/vol)
1-propanol, applied to a 2.25 cm x 22.5 cm Lichroprep RP-8, 25-40-dam bead size preparative
column and eluted with a stepwise gradient of 0-60% 1-propanol in 0.5 M acetic acid/1.0 M
pyridine, pH 5.5 buffer at a flow rate of 50 ml/min. Individual fractions were tested for
biological activity at a final dilution of 1/1,000 in culture. (B) Biologically active fractions
from A were pooled, adjusted to 20% 1-propanol, applied to a 0.45 cm x 22.5 cm analytical
Lichrosorb RP8 (10 urn) column, and eluted with a propanol gradient in the pH 5.5 buffer at
a flow rate of 0.22 ml/min. (C) Biologically active fractions from B were rechromatographed
with an expanded propanol gradient in the pH 5.5 buffer at a slow flow rate (0.22 ml/min).
Protein concentration is estimated using fluorescamine and an automated detection system
(15).
GAT-specific suppressive activity in both preparations was absorbed by and
eluted from GAT-, GT-, monoclonal antiJ
h-, PNA-, and anti-cGAT-Sepharose,
but not GA-Sepharose or monoclonal antiJq Sepharose. Responses to SRBC
were unaffected by any of these materials (not shown).
Molecular Weight Analysis of GAT-TsFR.
In a previous publication (6) we reported the apparent molecular weight of
GAT-TsFR from hybridoma 372133 .5 to be 48,000-63,000 as determined by
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TABLE I
Purification Summary ofGAT-TsFRfrom Hybridoina 372B3.5
*Protein concentration determined by fluorescamineand an automated detection system (15).
t Biological activity is measured by the ability to suppress a GAT-specific PFC responses in vitro and
is expressed as S5o units, the reciprocal of the dilution required to suppress the response by 50%.
TABLE II
Partial Serological Characterization of 372B3.5
GAT-specific PFC/Culture
*Crude and HPLC-purified culture supernatant fluids from hybridoma 372133.5 were reacted with
the indicated immunoabsorbent; the effluent and material eluted with 2.0 M KCl were tested for
biological activity at a final dilution in culture of 1/ 10,000 . Data are presentedas IgGGAT-specific
PFC/culture. Response in the absence of added GAT-TsFR was 503 PFC/culture.
nu, monoclonal anti-IJ reagents.
chromatography on Sephacryl S-200 at physiological pH and ionic strength. The
molecular weight of GAT-TsFR was determined under different conditions by
three independent methods. Supernatant fluids were applied to a Sephacryl 5-
200 column and analysis of individual fractions for biological activity showed
that GAT-TsFR eluted with phosphate-buffered saline (0.15 M, pH 7.5) had a
molecular weight in the range from ^-46,000 to 68,000 (Fig. 2 A) whereas,
when eluted with high ionic strength acetate buffer (0.5 M sodium acetate, pH
5.5), GA'T-TsFR had a molecular weight of 16,000-21,000 (Fig. 2 B). This
observation suggests that GAT-TsFR aggregates under physiological conditions
(see Discussion) . Molecular sieve chromatography by HPLC using TSK resins
anda 0.5 M acetic acid/1 .0 M pyridine pH 5.5 buffer yielded a molecular weight
of 18,000-21,000 for GAT-TsFR (Fig. 3).
The degree of purity and estimation of molecular weight of GAT-TsFR from
372B3.5 was also determined at each step of purification by SDS-PAGE under
reducing and nonreducing conditions. Biologically active fractions from HPLC
were lyophilized in the presence of 0.5% SDS to prevent adherence to the tube
and applied to a 12 .5% acrylamide gel. Fig. 4 represents the electrophoretic
Immunoabsorbent* Crude
Effluent
372133.5
Eluate
Purified 372133.5
Effluent Eluate
None 83 35
GAT-Sepharose 450 13 435 <10
GT-Sepharose 488 75 430 <10
GA-Sepharose 43 435 <10 405
me AntiJ°-Sepharose* 460 23 480 <10
me AntiJ9-Sepharoset 105 533 <10 450
PNA-Agarose 505 25 550 <10
Anti-cGAT-Sepharose 433 85 370 <10
Step Total protein*
ng
Bioactivity
S5o 0
Specific activity
S5o Ul ng protein
Purification
factor
Crude supernate 5.88 X 10" 400 x 10' 6.8 x 10-3 1
Lichroprep RP-8 1.22 x 10" 220 X 10' 1.8 X 10' 2.6 X 103
Lichrosorb RP-8 9.3 X 105 500 x 10' 53.8 x 102 7.9 x 105
Lichrosorb RP-8 8.8 X 105 2,500 x 10' 28 .4 x 103 4.2 x 106CRAIG M. SORENSEN, CARL W. PIERCE, AND DAVID R. WEBB
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Supernatant fluid from 372133.5 was concentrated by lyophilization, applied to a
14 cm x 50 cm Sephacryl S-200 column and eluted with either 0.15 M phosphate-buffered
saline, pH 7 .5 (Panel A) or 0.5 M sodium acetate, pH 5.5 (panel B). Individual fractions of 2
ml were collected and tested for biological activity at a final dilution of I/1,000. Arrows
indicate the elution volume of proteins of known molecular weights.
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Supernatant fluid from 372133.5 was concentrated by lyophilization, applied to a
tandem array of TSK 125 --* TSK 250 molecular sieve HPLC columns and eluted at a flow
rate of 0.25 ml/min with 0.5 M acetic acid I M pyridine, pH 5.5 buffer. Individual fractions
were tested for biological activity at a final dilution of 1/1,000. Arrows indicate the elution
volume of proteins of known molecularweights.
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FIGURE 4. SDS-PAGE under nonreducing conditions of GAT-TsFR purified by HPLC .
Lanes A-E represent the five biologically active fractions from the second Lichrosorb RP-8
HPLC (panel C, Fig . 1) . Molecular weight standards are indicated by arrows . Protein samples
were applied to a 12.5% acrylamide resolving gel and bands were visualized by staining with
silver .
pattern under nonreducing conditions of the five individual fractions with
bioactivity from the second RP-8 HPLC (Fig . 1 C) ; four bands were observed
after staining with silver with molecular weights of 18,000, 28,000, 64,000,
84,000 . Amino acid composition analyses (Table 111) of these individual bands
eluted from a 12.5% gel were essentially identical suggesting aggregation of
lower molecular weight species into the larger forms . Similar results were
obtained by SDS-PAGE analysis under both nonreducing and reducing condi-
tions (data not shown), suggesting that GAT-TsFR is irreversibly aggregated or
that aggregation is not dependent upon disulfide bond formation .
The issue of aggregation was investigated further by applying purified GAT-
TsFR to two adjacent lanes of a 12.5% acrylamide gel and electrophoresing
under nonreducing conditions . Protein in one lane was visualized by silver
staining : the other lane was divided into 3-mm slices that were eluted with
phosphate-buffered saline and the material was tested for suppression of GAT-CRAIG M. SORENSEN, CARL W. PIERCE, AND DAVID R. WEBB
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TABLE III
Amino Acid Composition ofthe Four Biologically Active Molecular Weight
Species ofGAT-TsFRfrom HYbridoma 372B3.5*
*Purified 372B3.5 (-I lAg) was applied to a 12.5% SDS-acrylamide gel and
electrophoresed, and the gel was stained briefly by Coomassie Brilliant Blue.
Individual bands were cut out of the gel (see Fig. 4), eluted and subjected to
amino acid analysis as described in Materialsand Methods. Values reported are
mole percent of each amino acid recovered.
$.\"D, not determined.
§ Molecular weight species.
specific PFC responses at several dilutions. The results in Fig. 5 demonstrate
that GAT-specific suppressive activity was associated with all ofthe protein bands
seen by silver staining and was not found in areas of the gel where there was no
protein. Further analysis of the fractions of GAT-TsFR eluted from the SDS-
PAGE demonstrated that each molecular weight form was absorbed by and
eluted from a monoclonal anti-l Jb immunoabsorbent, demonstrating the pres-
ence of I-J determinants on all molecular weight forms (data not shown). The
question ofaggregation was also addressed byapplying samplesofpurified GAT-
TsFR to adjacent lanes of an isoelectric focusing gel with a pH gradient of 4 to
10. One lane was divided into 3-mm slices, eluted, and material from individual
slices was tested for suppression of GAT-specific PFC responses; the protein in
the other lane was visualized by silver staining. Purified GAT-TsFR focused as a
single band with a pl of 6.4 and specific biological activity was associated only
with this band (Fig. 6). Finally, chemical purity of GAT-TsFR was also indicated
by the detection ofa single amino acid, aspartic acid, by N-terminal analysis and
partial sequence data (C. M. Sorensen, C. W. Pierce, and D. R. Webb, manuscript
in preparation) .
Discussion
Fusion ofGAT-specific suppressor Tcells from genetic responder C57BL/10
mice with the AKR thymoma, BW5147, yielded a hybridoma, 372133.5, which
18,000§ 28,000 64,000 84,000
Asx 8.1 7.5 7.5 7.9
Thr 2.4 2.7 3.0 2.2
Ser 2.8 2.0 2.9 2.0
Glx 16.3 16.0 16.0 16.1
Pro ND$ ND$ ND$ NDt
Gly 12.1 12.0 11 .0 11 .0
Ala 7.5 7.9 7.0 9.0
Val 6.8 6.0 6.3 6.3
Met <1 .0 <1 .0 <1 .0 <1 .0
Ile 1.9 1.3 1.0 1 .8
Leu 14.5 14.2 15 .0 14 .5
Tyr 1.4 1.1 1.1 1.6
Phe 2.6 3.0 2.6 2.6
His 3.0 2.8 2.6 2.8
Lys 10.0 9.8 9.8 10 .0
Arg 5.8 5.1 5.9 5.0
Cys 0.0 0.0 0.0 0.0
Try ND$ ND$ ND$ NDt1042
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FIGURE 5 .
￿
SDS-PAGE of GAT-TsFR purified by HPLC . A sample from one biologically
active fraction (panel C, Fig. I ; lane C, Fig . 4) was applied in duplicate to a 12.5% acrylamide
gel and electrophoresed under nonreducing conditions . One lane was stained with silver to
visualize protein and the other was divided into 3-mm slices, the protein was eluted from the
gel and tested for biological activity at several dilutions . Activity is expressed as S5o units ;
molecular weight standards are indicated by arrows.
constitutively secretes a monoclonal suppressor factor, GAT-TsFR, into the
supernatant fluid . GAT-TsFR is a glycoprotein that bears determinants encoded
by the 11 subregion of the H-2 complex, has an antigen-binding site, and
determinants cross-reactive with idiotypic determinants of anti-GAT antibody
(6) (see Table 11) . This GAT-TsFR has been purified to apparent chemical
homogeneity by reverse phase HPLC techniques . Starting with 40 1 of superna-
tant fluid with a specific activity of 6 .8 X 10-3 S5o U/ng protein, the three-step
purification process yielded a final specific activity of 28 .4 X 103 S5o U/ng
protein, or a purification factor of 4.2 X 106 . Determination of purity is based
on analysis by SDS-PAGE, isoelectric focusing, amino acid composition, and the
yield of a single amino acid, aspartic acid, followingN-terminal cleavage .
The purification strategy used is based on that originally reported by Krupen
et al . (5), with two important modifications . Partial purification of supernatant
material by precipitation with 30% 1-propanol and initial reverse-phase HPLCCRAIG M. SORENSEN, CARL W. PIERCE,AND DAVID R. WEBB
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FIGURE 6 .
￿
Purified 372133 .5 (164 ng/lane) was applied to two adjacent lanes ofan isoelectric
focusing gel (pH 4-10) andfocused at a constant current of2.5 mA at 4 °C for 18 h . Following
determination of the pH gradient using a micro-electrode, one lane was visualized by staining
with silver and the other was divided into 3-mm slices and eluted into phosphate buffered
saline, pH 7, for 24 h at 4°C. Individual fractions were assayed for GAT-specific suppressive
activity at a final dilution of 1/1,000 . Data are expressed as percent suppression of a control
response of 595 IgGGAT PFC/culture .
using a preparative size Lichroprep RP-8 column eliminated the need for the
affinity chromatography step and reduced the loss ofGAT-TsFR due to nonspe-
cific adsorption to the affinity matrix . Subsequent analytical reverse phase HPLC
was performed using a 10-Mm-Lichrosorb RP-8 resin rather than the 5-Am resin
previously reported (5), which allows better resolution .
The molecular weight of 372133 .5 GAT-TsFR has been determined by several
independent methods. Chromatography of GAT-TsFR on Sephacryl S-200 in a
physiological buffer yielded a molecular weight of 46,000-68,000 . Chroma-
tography on Sephacryl S-200 in the presence of 0.5 M acetate, pH 5.5, yielded
a molecular weight of -16,000-21,000; an apparent molecular weight of
18,000-21,000 was also obtained by HPLC molecular sieve chromatography
using TSK resins . These data suggest that under physiological conditions GAT-
TsFR frequently forms aggregates, which is not surprising since GAT-TsFR is a
relatively hydrophobic protein that elutes in 40% propanol on a reverse phase
column .
Analysis of purified GAT-TsFR by SDS-PAGE shows four distinct protein
bands with molecular weights of 18,000, 28,000, 64,000, and 84,000 . The
possibility that these protein bands are actually multimers or aggregates of a
basic subunit is suggested by the comparable amino acid composition of the
individual bands . Additional experiments in which the gel was sliced and the1044
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protein eluted confirmed this interpretation by showing that GAT-specific sup-
pressive activity was associated with each of the four protein bands. Data from
isoelectric focusing gels also supports the contention that the individual bands
seen by SDS-PAGE analysis actually represent aggregated forms of a single
protein species. Under these conditions, the GAT-TsFR focused as a single band
with a discrete pl of 6.4. Furthermore, a direct positive correlation was seen
between protein bands and specific biological activity. The tendency of GAT-
TsFR to aggregate increases with the degree of purity and is most pronounced
when the protein is removed from the 40% 1-propanol buffer used in the HPLC
procedures into physiological phosphate buffer. This is best illustrated by the
appearance of the multiple biologically active bands on SDS-PAGE, while a
portion of the same sample chromatographed on a HPLC molecular sieve TSK
column produces only a single peak of biological activity. Unlike SDS-PAGE
analysis in which the propanol is removed, the HPLC molecular seive analysis
does not require removal of the 40% 1-propanol buffer and is performed under
different dissociating conditions, thereby preventing the formation of extensive
aggregates. The presence ofpropanol alone isnot sufficient toprevent aggregate
or multimer formation; purified GAT-TsFR stored for prolonged periods oftime
in 40% propanol buffer will eventually precipitate out ofsolution, again empha-
sizing the hydrophobic nature ofthe protein. Aggregation is virtually irreversible
once it has occurred. Analysis by SDS-PAGE under reducing conditions or
treatment with thioglycollic acid fails to disrupt the aggregates. Treatment with
10 mM dithiothreitol overnight at 40°C under nitrogen only partially reduces
the large molecular weight aggregates (C. Sorensen, unpublished observations).
The sizes of the aggregates or multimers that are formed are also of interest .
The smallest biologically functional unit is an 18,000 mol wt protein (glycopro-
tein) whose precise relationship to the predominant 28,000 mol wt and larger
forms is unclear. One interpretation is that the 18,000 mol wt form is actually a
breakdown product of the major 28,000 mol wt form that has retained all of the
function and serological determinants detected on the larger molecule (6). At
this time we cannot rule out this possibility. An alternate interpretation is that
the 18,000 cool wt species is actually a "monomeric subunit" of the major
biologically active dimeric form (Figs. 4 and 5). One interesting possibility
suggested by these observations is that biological activity of GAT-TsFR requires
dimerization to form a functional molecule similar to immunoglobulin molecules.
The discrepancy in molecular weight from what is predicted for dimerization
of the 18,000 cool wt species, a ^-36,000 mol wt species, to the observed 28,000
inol wt species may be explained by the somewhat anomalous behavior of
glycoproteins analyzed by SDS-PAGE or by changes in glycosylation resulting
from purification. Any differences in glycosylation or degree of glycosylation
presumably do not involve the loss ofsialic acid residues since charge heteroge-
neity is not detected by isoelectric focusing analysis. Analysis ofthe carbohydrate
content and structure(s) on the purified GAT-TsFR molecule is in progress.
The formation of aggregates provide an explanation for the previous reports
ofa larger molecular weight for GAT-TsFR when determination is by molecular
sieve analysis with physiological buffers. Other suppressor T cell factors from
genetic nonresponders to GAT also exhibit this phenomenon of aggregation toCRAIG M . SORENSEN, CARL W. PIERCE, AND DAVID R. WEBB
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varying degrees (C. Healy, personal communication), suggesting that this is a
characteristic of this class of proteins . Another feature common to all of the
hybridoma-derived suppressor T cell factors specific for GAT purified to date is
the failure to chromatograph by HPLC as a single sharp peak (see Fig. 1 C);
instead, these molecules elute as a relatively broad peak ofbioactivity andprotein
but with a highly reproducible retention time in 40% propanol. The reasons for
this are unclear, but again may be due to changes in glycosylation induced by
the purification process, changes in degree of aggregation, or subtle differences
in oxidation/reduction states of the sample applied to the column. Any one of
these alterations or differencesare capable ofbeingdetected by HPLC techniques
and would result in broadening of the peak .
An important conclusion from these results and data from purification of the
nonresponder GAT-TsF from hybridoma 258C4.4 (5) is that these GAT-specific
suppressor T cell factors may represent a family of proteins exhibiting rather
unique biochemical characteristics, including similar retention times using re-
versed phase HPLC (elution from RP-8 resin in 40% propanol), amino acid
composition, degree of hydrophobicity and the tendency to form higher molec-
ular weight aggregates. These shared characteristics appear to be independent
of antigenic fine specificity; haplotype of origin or responder vs. nonresponder
status. GAT-TsFR from hybridoma 372113 .5 has specificity for GAT and GT,
bears an IJb determinant, and is derived from an H-26 responder mouse (6),
whereas GAT-TsF from hybridoma 258C4.4 has specificity for GAT and GA
bears a putative IJq determinant and is derived from an H-2q nonresponder
mouse (4, 5). Independent experiments reported elsewhere have shown that
GAT-TsFR from 372113.5 and GAT-TsF from 258C4.4 are single polypeptide
chains with both IJ-encoded determinants and antigen-binding sites on the same
molecule (20).2 We predict that any significant differences between these mole-
cules will be at the structural level and will be very restricted, reflecting fine
antigen specificity or "VH" region and individual haplotype differences . Further
analysis involving determination of repertoire diversity within a haplotype,
between haplotypes and between responder and nonresponder strains is now
possible for antigen-specific suppressor T cell factors and is in progress.
Summary
A hybridoma-derived, GAT-specific suppressor Tcell factor (GAT-TsFR)from
responder C57BL/10 mice has been purified to apparent chemical homogeneity
using reversed phase HPLC techniques. 40 1 of starting material yielded ^-880
Ag protein with a specific activity of 28.4 X 10 3 S50 U/ng protein representing a
purification factor of 4.2 X 106. Purified GAT-TsFR is a hydrophobic protein
with a minimum molecular weight of 18,000 that is capable of forming biologi-
cally active aggregates with molecular weights of 28,000, 64,000 and ^-84,000
and has a pI of 6.4. GAT-TsFR is a glycoprotein that binds GAT and GT, but
not GA, andbears determinants encoded by the I-j subregion ofthe H-2 complex.
This GAT-TsFR derived from an H-26 responder haplotype to GAT is compared
z Kapp, J. A., C. M . Sorensen, and C. W. Pierce. 1983. Antigen-specific suppressor T cell
interactions. II . Characterization of MHC-restricted factors specific for t.-glutamic acid"-t.-tyrosine'°
(GT) and t=glutamic acid"-t.-alanines°-t.-tyrosine" (GAT) (Submitted for publication).1046
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with GAT-TsF derived from the nonresponder H-29 haplotype on the basis of
biochemical and some serological properties.
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critical commentary on the manuscript.
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